Skip to main content

Bausch Health Companies Inc. (BHC)

Sector
Pharmaceuticals
Last price
$8.42
As of

Kresmion compiles this page from BHC's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Bausch Health Companies Inc. (BHC): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q3 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-10-29.

As of . Source: SEC EDGAR filings for BHC. Method and limitations.

COMPANY DOSSIER

See the full BHC dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for BHC on one page. Preview it with sample data, then open it live with a free account.

Preview the BHC dossier

Active events for BHC

FREE, NO ACCOUNT

Every event on BHC, as it fires

You are seeing 5 of 12 events recorded on BHC since 2026-05-30.

The five above landed across 4 days. The other 7 were recorded on 2 other days. 6 of the 12 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

BHC positions held by the managers we follow (2026Q3)

What the managers we follow bought and sold in Q2 2026

Manager / securityMarket value% of reported value
RENAISSANCE TECHNOLOGIES LLC FundCUSIP 071734107 · 2026Q3$12M0.02%

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, BHC

More data on BHC

BHC against its peers

BHC's operating margin of 17.7% ranks in the 78th percentile of 19 Pharmaceuticals sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.

MetricBHCPeer medianPercentilen
Revenue FY10.3B USD638M USD9821
Gross marginn/a74.8%n/a11
Operating margin17.7%5.9%7819
Net margin1.5%0.6%5520
Return on equityn/a-6.5%n/a22
P / E20.0x17.0x5910
1 year39.2%-3.9%6624

Peers (25): XERS, OGN, TARS, AMLX, HRMY, TRVI, LQDA, SUPN, ANIP, NUVB, PCRX, AMRX, PAHC, GPCR, AXSM, OCUL, INVA, NKTR, CORT, AMPH, OMER, ANRO, ESPR.D, COLL, ALMS. Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (BHC: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

Cite this data

Kresmion counts the managers it follows that reported a non-option position in BHC on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on BHC in the last 180 days.

Upstream: SEC EDGAR filings for BHC

Kresmion, "Bausch Health Companies Inc. (BHC) institutional holdings and SEC filings", data as of 2026-11-16, https://kresmion.com/research/BHC. Upstream data: SEC EDGAR filings for BHC.

Link to this data (HTML):

<a href="https://kresmion.com/research/BHC">Bausch Health Companies Inc. (BHC) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow BHC on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to BHC for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the BHC dossier
Share

The BHC intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.